No Sales BS, please. Just the facts, ma'am.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Trading right in the middle of the days rnge. Another sideways move.
Even on a slow day that volume adds up consistently to be quite strong over the weeks and months.
Yup sometimes we miss the forest for the trees. When you evaluate LXGTF, in almost every area, from the stock, to market analytics to the FDA clearance you can always get the most profitable view when you step back and take the 30th view
I think endoPAT also requires about $40 on consumables
And EndoPAT can't even compete on terms of cost point, convenience, even accuracy. LXGTF HeartSentry will dominate from the beginning of its clearance by FDA
Up green 62% I stand corrected.
OK Google it and got this " EndoPAT is an Innovative, safe and non-invasive diagnostic device for Functional Vascular Health Assessment for both large and small arteries. It is the only FDA cleared non-invasive test to evaluate the level of Endothelial Function." So basically the only direct FDA cleared competitor to LXGTF.
March back up begins tommorow.
By the way, I know what an ultrasound scan is like, but has anyone ever had an EndoPAT procedure? What is that even?
Nice volume today. Weak hands get shaken, longs snap it up. Bounce is soon here.
That's right and only HeartSentry technology measures that function cheaply and simply. There is literally nothing like it on the market.
Whatever else you want to say about the way LXGTF trades 2 things you must admit:1) the volume hence liquidity is very consistent. For months now. 2)The massive support just won't let it slip much, even on a red day
I mean if Rogaine can make a fortune curing some of male baldness, then definitely there is some big market share awaiting a device that addresses and diverts from heart attack and stroke.
It's also different when you have a product that literally will save lives. This is not about some obscure disease. This is 33% of the deaths in the modern world, 50 % of which have no advance warning of onset. LXGTF HS monitor rectifies that. If that's it a medical breakthrough then what is?
Right now this is the very definition of oversold. Get them at this level while it lasts
Seems parked here churning just under 6. But not for long.
Yes, we have here something that actually can stop the biggest disease killer in the modern world. If the very purpose of the Biomedical sector is not to save and extend life then what is the purpose?
It's the way the free market operates. Finally we have an affordable, practical solution that actually predicts the 50% of heart cases that were attacking without warning. How can it not be huge.
FERN management seems to have a penchant for the big dramatic reveal. Investors get to reap that benefit.
It's October all over again. It either means the bounce will come in the Yuletide days or its going to be one doozie of a Happy New Year for LXGTF.
Holy cow, up 80%, met too I should be mortgaged my kidneys and loaded up discounted RAKR
I think obviously the trend in all market tiers will show the most dramatic volatility in crypto stocks during the upcoming months. I invest there too. LXGTF however is a different kind of play. We continue to see consistent volume and a steady 3 months uptick due to tons of grass roots organic investor interest. But we will see the biggest pop in upcoming months when the FDA clearance I attained.
HeartSentry is based on patented, peer reviewed, decade long research coming out of Nobel prize winning Berkeley Labs. Dr. Johnathan Maltz chief researcher is on the board of LXGTF.
50% of all heart attacks have no advance warning before the heart attack itself. LG solves this dilemma.
The big problem is that the biggest killer in the modern world, heart attack and stroke, can't be diagnosed reliably and practically with existing methods. Endothelial diagnosis using the HeartSentry monitor is reliable and affordable and most importantly accurate in diagnosing impending episodes of heart attack or stroke.
HeartSentry tech grasps that only endothelial health diagnoses can warn of impending heart disease or stroke.
Building in some new strong support today. Shaking out the weak hands. Need to shake out the swing traders so we can bounce past 2.
Great move today here for FVRD
Tomorrow we break the 25 resistance
2s are a great bargain. Get them while it lasts.
This lateral trading is almost been the trend all week for LXGTF
That's a good way to put where we are.
Up 46%. Nice green move for RAKR!
About time we had some good news here. RAKR has many irons in the fire to share.
I think we've hit bottom for now. Time to grab a few more.
I don't like seeing it in the 5's
Churn churning in the 6s very gratifyijg.to not see it slipping further. Lots of support accumulating. A vindication to those who bought last mid week and a sign of more to come.
Slow volume day but up green and she never stops trading
Cmon FVRD! Break that 25 resistance alright!